These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


150 related items for PubMed ID: 1322547

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical application of PET for the evaluation of brain tumors.
    Coleman RE, Hoffman JM, Hanson MW, Sostman HD, Schold SC.
    J Nucl Med; 1991 Apr; 32(4):616-22. PubMed ID: 2013802
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
    Valk PE, Budinger TF, Levin VA, Silver P, Gutin PH, Doyle WK.
    J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Positron emission tomographic study of suppression of gray-matter glucose utilization by brain tumors.
    DeLaPaz RL, Patronas NJ, Brooks RA, Smith BH, Kornblith PL, Milam H, Di Chiro G.
    AJNR Am J Neuroradiol; 1983 Dec; 4(3):826-9. PubMed ID: 6308993
    [Abstract] [Full Text] [Related]

  • 8. Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy.
    Pirotte B, Goldman S, Bidaut LM, Luxen A, Stanus E, Brucher JM, Balériaux D, Brotchi J, Levivier M.
    Acta Neurochir (Wien); 1995 Dec; 134(1-2):79-82. PubMed ID: 7668134
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. PET-FDG of pleomorphic xanthoastrocytoma.
    Bicik I, Raman R, Knightly JJ, Di Chiro G, Fulham MJ.
    J Nucl Med; 1995 Jan; 36(1):97-9. PubMed ID: 7799091
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) of brain tumors.
    Rozental JM.
    Neurol Clin; 1991 May; 9(2):287-305. PubMed ID: 1944100
    [Abstract] [Full Text] [Related]

  • 13. Positron emission tomography imaging-directed stereotactic neurosurgery.
    Maciunas RJ, Kessler RM, Maurer C, Mandava V, Watt G, Smith G.
    Stereotact Funct Neurosurg; 1992 May; 58(1-4):134-40. PubMed ID: 1439330
    [Abstract] [Full Text] [Related]

  • 14. Assessment of malignancy of glioma by positron emission tomography with 18F-fluorodeoxyglucose and single photon emission computed tomography with thallium-201 chloride.
    Tamura M, Shibasaki T, Zama A, Kurihara H, Horikoshi S, Ono N, Oriuchi N, Hirano T.
    Neuroradiology; 1998 Apr; 40(4):210-5. PubMed ID: 9592789
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Enhanced detection of brain tumors by [18F]fluorodeoxyglucose PET with glucose loading.
    Ishizu K, Sadato N, Yonekura Y, Nishizawa S, Magata Y, Tamaki N, Tsuchida T, Okazawa H, Tanaka F, Miyatake S.
    J Comput Assist Tomogr; 1994 Apr; 18(1):12-5. PubMed ID: 8282860
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
    Glantz MJ, Hoffman JM, Coleman RE, Friedman AH, Hanson MW, Burger PC, Herndon JE, Meisler WJ, Schold SC.
    Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.